ARK Genomic Revolution ETF (ARKG)
28.22
-0.22
(-0.77%)
USD |
BATS |
Mar 18, 16:00
28.25
+0.03
(+0.11%)
After-Hours: 20:00
Price Chart
Key Stats
Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
---|---|---|---|
0.75% | -0.05% | 1.591B | 2.446M |
Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
0.00% | 28.00% | -157.20M | Upgrade |
Basic Info
Investment Strategy | |
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Small Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | Sector Equity |
Broad Category | Equity |
Category Name | Health |
Category Index | S&P 1500 Health Care TR |
Global Category Name | Healthcare Sector Equity |
YCharts Categorization | Healthcare Equity |
YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
Prospectus Objective | Specialty - Unaligned |
Fund Owner Firm Name | ARK ETF Trust |
Prospectus Benchmark Index | |
NASDAQ Health Care GR EUR | 100.0% |
Broad Asset Class Benchmark Index | |
^MSWNTR | 100.0% |
Manager Tenure | |
Catherine Wood | 9.34 yrs |
Performance Versus Category
As of March 18, 2024. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of March 18, 2024.
Basic Info
Investment Strategy | |
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Small Cap/Growth |
Fixed Income Style | -- |
Broad Asset Class | Sector Equity |
Broad Category | Equity |
Category Name | Health |
Category Index | S&P 1500 Health Care TR |
Global Category Name | Healthcare Sector Equity |
YCharts Categorization | Healthcare Equity |
YCharts Benchmark | S&P 1500 Health Care (Sector) Total Return (^SP15HCSTR) |
Prospectus Objective | Specialty - Unaligned |
Fund Owner Firm Name | ARK ETF Trust |
Prospectus Benchmark Index | |
NASDAQ Health Care GR EUR | 100.0% |
Broad Asset Class Benchmark Index | |
^MSWNTR | 100.0% |
Manager Tenure | |
Catherine Wood | 9.34 yrs |